IDH1 and ovarian carcinoma: Colorectal cancer, triple negative breast cancer, Pancreatic cancer, non-small cell lung cancer, Head and neck cancer, Ovarian cancer, Lymphoma, sarcoma, Bladder cancer, Melanoma, IDH1 Mutated solid tumors, IDH1 Mutated or MGMT methylated recurrent HGG (Not Recruiting)